Literature DB >> 27249600

MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop.

X-J Wang1, D-L Zhang, C Fu, B-Z Wei, G-J Li.   

Abstract

OBJECTIVE: MiR-183 acts as an oncomiR and is usually upregulated in hepatocellular cancer (HCC). This study aims to study the association between miR-183 dysregulation and multi-drug resistance (MDR). Also, how it is dysregulated in HCC cells was investigated.
MATERIALS AND METHODS: The association between miR-183 and HIF-1α in HCC cell line BEL-7402 and the multidrug-resistant variant BEL-7402/5-fluorouracil (BEL-7402/5-FU) were studied using qRT-PCR and Western blot analysis. The mediators involved in feedback regulation between miR-183 and HIF-1α were further studied. Then, the effect of the miR-183-SOCS6 axis on IC50 of BEL-7402/5-FU cells to 5-FU were investigated by MTT assay.
RESULTS: The expression of miR-183 and HIF-1α are positively correlated in BEL-7402 and BEL-7402/5-FU cells. IDH2 knockdown resulted in significantly increased HIF-1α expression in both BEL-7402 and BEL-7402/5-FU cells. Knockdown of SOCS6 had similar but stronger effect as miR-183 in promoting MRP2, P-gp, p-STAT3 and HIF-1α expression in BEL-7402 cells, while SOCS6 overexpression also showed similar but stronger effect as miR-183 inhibition in reducing MRP2, P-gp, p-STAT3 and HIF-1α levels in BEL-7402/5-FU cells. Both SOCS6 overexpression and miR-183 knockdown significantly increased the sensitivity of BEL-7402/5-FU cells to 5-FU. MiR-183 overexpression partly abrogated the effect of SOCS6 in enhancing 5-FU sensitivity.
CONCLUSIONS: Both HIF-1α-miR-183-IDH2-HIF-1α and HIF-1α-miR-183-SOCS6-p-STAT3-HIF-1α feedback loops are involved in miR-183 upregulation in HCC cells. MiR-183 can modulate MDR of HCC cells at least partly through suppressing SOCS6.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27249600

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  17 in total

Review 1.  Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Bo Cao; Xin Zhou; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

2.  Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.

Authors:  Shengshu Li; Xiaoxin Lu; Dongyang Zheng; Weizong Chen; Yuzhu Li; Fang Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-30       Impact factor: 4.322

3.  miR-183-5p enhances the radioresistance of colorectal cancer by directly targeting ATG5.

Authors:  Sheng Zheng; Yong-Fu Zhong; DE-Ming Tan; Yue Xu; Huai-Xiang Chen; Dan Wang
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

4.  Regulation of MRP4 Expression by circHIPK3 via Sponging miR-124-3p/miR-4524-5p in Hepatocellular Carcinoma.

Authors:  Haihong Hu; Yu Wang; Zhiyuan Qin; Wen Sun; Yanhong Chen; Jiaqi Wang; Yingying Wang; Jing Nie; Lu Chen; Sheng Cai; Lushan Yu; Su Zeng
Journal:  Biomedicines       Date:  2021-04-30

5.  PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis.

Authors:  Tuotuo Gong; Shuyu Zheng; Shan Huang; Shenbo Fu; Xuanwei Zhang; Shupei Pan; Tian Yang; Yuchen Sun; Ya Wang; Beina Hui; Jia Guo; Xiaozhi Zhang
Journal:  Mol Carcinog       Date:  2017-08-21       Impact factor: 4.784

6.  Knockdown of miR-183 Enhances the Cisplatin-Induced Apoptosis in Esophageal Cancer Through Increase of FOXO1 Expression.

Authors:  Hao Chen; Bin Zheng; Songtao Xue; Chun Chen
Journal:  Onco Targets Ther       Date:  2020-08-24       Impact factor: 4.147

7.  The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p.

Authors:  Xi Lan; Nan Wu; Litao Wu; Kai Qu; Ezra Kombo Osoro; Dongxian Guan; Xiaojuan Du; Bo Wang; Sifan Chen; Ji Miao; Juan Ren; Li Liu; Haiyun Li; Qilan Ning; Dongmin Li; Shemin Lu
Journal:  Mol Ther Nucleic Acids       Date:  2020-03-20       Impact factor: 8.886

Review 8.  The interplay between HIF-1α and noncoding RNAs in cancer.

Authors:  Xiafeng Peng; Han Gao; Rui Xu; Huiyu Wang; Jie Mei; Chaoying Liu
Journal:  J Exp Clin Cancer Res       Date:  2020-02-03

Review 9.  Non-coding RNA in drug resistance of hepatocellular carcinoma.

Authors:  Bisha Ding; Weiyang Lou; Liang Xu; Weimin Fan
Journal:  Biosci Rep       Date:  2018-10-09       Impact factor: 3.840

Review 10.  The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.

Authors:  Ling Wei; Xingwu Wang; Liyan Lv; Jibing Liu; Huaixin Xing; Yemei Song; Mengyu Xie; Tianshui Lei; Nasha Zhang; Ming Yang
Journal:  Mol Cancer       Date:  2019-10-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.